| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
| 09/29/2009 | CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives |
| 09/29/2009 | CA2253943C Treatment of asthma and airway diseases |
| 09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/27/2009 | CA2627198A1 Methylphenidate extended release therapeutic drug delivery system |
| 09/24/2009 | WO2009117739A1 Modulators of nuclear receptor co-regulatory protein binding |
| 09/24/2009 | WO2009117710A2 Methods of treating inflammation |
| 09/24/2009 | WO2009117677A2 Methods for controlling intracellular calcium levels associated with an ischemic event |
| 09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117669A2 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | WO2009117668A1 Improved method and process for synthesis of 2',3'-didehydro-2',3'-dideoxynucleosides |
| 09/24/2009 | WO2009117659A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117657A1 Healthful composition |
| 09/24/2009 | WO2009117621A1 Pest control compositions and methods |
| 09/24/2009 | WO2009117597A1 Modulation of the immune response |
| 09/24/2009 | WO2009117596A1 Adaptive biochemical signatures |
| 09/24/2009 | WO2009117589A1 Oligomeric compounds comprising tricyclic nucleosides and methods for their use |
| 09/24/2009 | WO2009117584A2 Anti-inflammatory drug delivery system |
| 09/24/2009 | WO2009117558A2 Destruction of microbial products by enzymatic digestion |
| 09/24/2009 | WO2009117540A1 Bridged heterocycles as hiv integrase inhibitors |
| 09/24/2009 | WO2009117465A1 Substituted gamma lactams as prostaglandin ep2 agonists |
| 09/24/2009 | WO2009117444A1 Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| 09/24/2009 | WO2009117410A2 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques |
| 09/24/2009 | WO2009117401A2 Compositions for site-specific delivery of imatinib and methods of use |
| 09/24/2009 | WO2009117378A2 Therapeutic amides |
| 09/24/2009 | WO2009117367A1 Method for treating cancers having high glucose requirements employing an sglt2 inhibitor and compositions thereof |
| 09/24/2009 | WO2009117352A1 Cancer treatment method |
| 09/24/2009 | WO2009117335A2 S1p3 receptor inhibitors for treating inflammation |
| 09/24/2009 | WO2009117333A1 Dithiocarbamate metal chelates and methods of making and using thereof |
| 09/24/2009 | WO2009117316A2 Pharmaceutical compositions having desirable bioavailability |
| 09/24/2009 | WO2009117283A2 Quinolizidinone m1 receptor positive allosteric modulators |
| 09/24/2009 | WO2009117277A2 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 09/24/2009 | WO2009117269A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | WO2009117242A2 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 09/24/2009 | WO2009117166A2 Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole) |
| 09/24/2009 | WO2009117160A2 Compound and method for treatment of gastroesophageal reflux |
| 09/24/2009 | WO2009117157A1 Aurora kinase modulators and method of use |
| 09/24/2009 | WO2009117156A1 Pyrazolo-pyrazinone compounds and methods of use thereof |
| 09/24/2009 | WO2009117152A1 Emulsions including a peg-derivative of tocopherol |
| 09/24/2009 | WO2009117151A2 Compositions containing non-polar compounds |
| 09/24/2009 | WO2009117150A2 Method of treating lupus with ceramide derivatives |
| 09/24/2009 | WO2009117144A1 Benzazepine compounds |
| 09/24/2009 | WO2009117130A2 Extended release forumulation containing a wax |
| 09/24/2009 | WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | WO2009117097A1 Novel tyrosine kinase inhibitors |
| 09/24/2009 | WO2009117095A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/24/2009 | WO2009117080A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof |
| 09/24/2009 | WO2009117036A2 Bioactive molecules from co-cultivation of microbes |
| 09/24/2009 | WO2009117024A1 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis |
| 09/24/2009 | WO2009116896A1 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
| 09/24/2009 | WO2009116888A1 Pharmaceutical composition for preventing and treating bone resorption of different etiology |
| 09/24/2009 | WO2009116887A1 Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 09/24/2009 | WO2009116886A1 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
| 09/24/2009 | WO2009116882A1 Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol |
| 09/24/2009 | WO2009116774A2 Composition for treatment or prevention of restenosis |
| 09/24/2009 | WO2009116604A1 Wickerol and process for production thereof |
| 09/24/2009 | WO2009116557A1 Drug-containing composition |
| 09/24/2009 | WO2009116556A1 Pharmaceutical composition for injection |
| 09/24/2009 | WO2009116546A1 Excitatory chemical mediator and method for screening thereof |
| 09/24/2009 | WO2009116509A1 Polymer conjugate of physiologically active substance |
| 09/24/2009 | WO2009116507A1 Enteral nutrient |
| 09/24/2009 | WO2009116490A1 Remedy for meniere's disease |
| 09/24/2009 | WO2009116450A1 Elastase activity inhibitor |
| 09/24/2009 | WO2009116257A1 Therapeutic agent for fibroid lung |
| 09/24/2009 | WO2009116086A2 Stable fixed dose topical formulation |
| 09/24/2009 | WO2009116078A2 Oral dosage formulations and process of preparation thereof |
| 09/24/2009 | WO2009116077A2 Injectable preparations and a process of preparation thereof |
| 09/24/2009 | WO2009116076A2 Sterile opthalmic preparations and a process for preparation thereof |
| 09/24/2009 | WO2009116067A2 Novel derivatives of acyl cyanopyrrolidines |
| 09/24/2009 | WO2009116061A2 Stable oral pharmaceutical composition comprising atorvastatin |
| 09/24/2009 | WO2009116055A1 Lamivudine : zidovudine : water 1 : 1 : 1 cocrystal |
| 09/24/2009 | WO2009115954A1 Dosing regimen for a selective s1p1 receptor agonist |
| 09/24/2009 | WO2009115906A2 An improved process for preparation of carvedilol involving halohydrin derivative |
| 09/24/2009 | WO2009115874A2 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation |
| 09/24/2009 | WO2009115834A2 Hormone inhibition |
| 09/24/2009 | WO2009115807A1 Inhibitors of the aryl hydrocarbon receptor for modulating the immune response |
| 09/24/2009 | WO2009115707A2 Preparation of hydroquinone amide compounds with antioxidant properties. |
| 09/24/2009 | WO2009115685A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
| 09/24/2009 | WO2009115669A1 Combination of a sinusal if current inhibitor and a beta-blocker |
| 09/24/2009 | WO2009115666A2 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria |
| 09/24/2009 | WO2009115665A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors |
| 09/24/2009 | WO2009115652A2 Composition and methods used during anti-hiv treatment |
| 09/24/2009 | WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/24/2009 | WO2009115634A1 Synergic 5'-methylthioadenosine combinations |
| 09/24/2009 | WO2009115562A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 09/24/2009 | WO2009115547A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 09/24/2009 | WO2009115534A1 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl] propane-1, 3-diols |
| 09/24/2009 | WO2009115517A2 Organic compounds |
| 09/24/2009 | WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 09/24/2009 | WO2009115510A1 Antiviral formulation |
| 09/24/2009 | WO2009115503A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | WO2009115496A1 Furo [3, 2-d] pyrimidine derivatives as h4 receptor antagonists |
| 09/24/2009 | WO2009115486A1 Triazole amide derivatives for use in therapy |
| 09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | WO2009115427A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | WO2009115398A1 Vitamin d compounds for the treatment of biliary diseases |